glp-1 agonists: Comparing Ozempic, Wegovy and Other Drugs GLP-1R and Diabetes
Description
Monotherapy showed higher AE rates
However, the cost of sitagliptin and the need for more data may restrict its use
DPP-4 inhibition is an interesting line of therapy for treating Type 2 Diabetes Mellitus (T2DM) and is based on promoting the incretin effect
Glucagon-like peptide-1 (GLP-1) is a 30-amino acid hormone secreted by L cells in the distal ileum, colon, and pancreatic cells, which participates in bloo...
Now Pfizers public declaration that its at the end of the beginning in entering the GLP1 market marks a pivotal
GLP-1 drugs address those factors
